Option Care Health Inc. (OPCH) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.43	$0.45	+4.7%	—	$1.4B	—
Q1 26	$0.37	$0.4	+8.1%	—	$1.4B	—
Q4 25	$0.47	$0.46	-2.1%	—	$1.5B	—
Q3 25	$0.43	$0.45	+4.7%	—	$1.4B	—
Q2 25	$0.4	$0.41	+2.5%	—	$1.4B	—
Q1 25	$0.34	$0.4	+17.6%	—	$1.3B	—
Q4 24	$0.37	$0.37	0.0%	—	$1.3B	—
Q3 24	$0.32	$0.33	+3.1%	—	$1.3B	—
Q2 24	$0.28	$0.31	+10.7%	—	$1.2B	—
Q1 24	$0.22	$0.27	+22.7%	—	$1.1B	—
Q4 23	$0.29	$0.31	+6.9%	—	$1.1B	—
Q3 23	$0.29	$0.33	+13.8%	—	$1.1B	—
Q2 23	$0.24	$0.3	+25.0%	—	$1.1B	—
Q1 23	$0.18	$0.21	+16.7%	—	$1B	—
Q4 22	$0.24	$0.24	0.0%	—	$1B	—
Q3 22	$0.24	$0.21	-12.5%	—	$1B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$1.28	—	—	$5.6B	—
FY24	—	$1.23	—	—	$5B	—
FY23	—	$1.49	—	—	$4.3B	—
FY22	—	$0.83	—	—	$3.9B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$935.6M	$817.2M	$1.9B	$2.3B	$3B	$3.4B	$3.9B	$4.3B	$5B	$5.6B
YoY change	-4.75%	-12.7%	+137.4%	+19.1%	+31.3%	+13.4%	+14.7%	+9.06%	+16.2%	+13%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	935.6M	817.2M	1.9B	2.3B	3B	3.4B	3.9B	4.3B	5B	5.6B
Cost of revenue	673.5M	547.9M	1.5B	1.8B	2.4B	2.7B	3.1B	3.3B	4B	4.6B
Gross profit	262.1M	269.2M	422.2M	513M	682.3M	779.6M	866.9M	981.2M	1B	1.1B
Gross margin	28%	32.9%	21.8%	22.2%	22.5%	22.7%	22%	22.8%	20.3%	19.3%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	38.8M	39.6M	345.9M	459.6M	500.2M	525.7M	566.1M	607.4M	630.3M	682.5M
Operating expenses	208.6M	202.9M	500.7M	459.6M	500.2M	525.7M	566.1M	607.4M	630.3M	682.5M
Operating income	31.5M	38.6M	38.3M	-319K	110.8M	190.8M	240.2M	314.6M	321.8M	337.9M
Operating margin	3.36%	4.73%	1.97%	-0.01%	3.65%	5.55%	6.09%	7.31%	6.44%	5.98%
Non-operating income, net	-28.1M	-54M	-1.2M	-4.2M	-8.2M	-7.3M	19.3M	95.4M	10.8M	-448K
Pretax income	-34.2M	-67.4M	-8.8M	-78.2M	-5.2M	116.5M	205.8M	358.7M	283.6M	282.9M
Income tax	2M	-4.1M	-2.7M	-2.3M	2.8M	-23.4M	55.2M	91.7M	71.8M	75.3M
Net income	-42.8M	-64.2M	-6.1M	-75.9M	-8.1M	139.9M	150.6M	267.1M	211.8M	207.6M
Net margin	-4.57%	-7.86%	-0.32%	-3.29%	-0.27%	4.07%	3.82%	6.21%	4.24%	3.67%
EBITDA	81.6M	120.3M	78.1M	53.4M	180.4M	252.3M	325M	472.2M	396.1M	408.1M
EPS	-2.16	-2.36	-1.96	-1.96	-0.04	0.78	0.83	1.49	1.23	1.28
Diluted EPS	-2.16	-2.36	-1.96	-1.96	-0.04	0.77	0.83	1.48	1.23	1.27

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	1.1B	1.1B	1.1B	1.2B	1.3B	1.3B	1.3B	1.4B	1.4B	1.5B	1.4B	1.4B
Cost of revenue	838.7M	877.3M	907.6M	977.8M	1B	1.1B	1.1B	1.1B	1.2B	1.2B	1.1B	1.2B
Gross profit	254.3M	247.1M	238.5M	249.4M	256.7M	268.4M	263.1M	269M	272.9M	282.9M	262M	267.3M
Gross margin	23.3%	22%	20.8%	20.3%	20.1%	19.9%	19.7%	19%	19%	19.3%	19.4%	18.5%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	158.2M	147.8M	154.7M	153.8M	157M	164.7M	168.1M	170.1M	172.1M	172.1M	174.6M	164.7M
Operating expenses	158.2M	147.8M	154.7M	153.8M	157M	164.7M	168.1M	170.1M	172.1M	172.1M	174.6M	164.7M
Operating income	81M	84.6M	69M	80.7M	85.1M	87M	79.2M	82.7M	84.5M	91.5M	72.5M	85.1M
Operating margin	7.42%	7.52%	6.02%	6.57%	6.66%	6.46%	5.94%	5.84%	5.89%	6.24%	5.37%	5.9%
Non-operating income, net	824K	6.8M	1.1M	4M	808K	4.9M	-2.4M	598K	-1.4M	2.7M	1.8M	2.9M
Pretax income	70.1M	78.9M	57M	72M	73.6M	81M	63.6M	68.9M	69M	81.5M	61M	74M
Income tax	13.8M	21.7M	12.2M	19M	19.7M	20.9M	16.8M	18.3M	17.2M	23M	15.7M	20.1M
Net income	56.3M	57.2M	44.8M	53M	53.9M	60.1M	46.7M	50.5M	51.8M	58.5M	45.3M	53.9M
Net margin	5.15%	5.09%	3.91%	4.32%	4.21%	4.47%	3.51%	3.57%	3.61%	3.99%	3.36%	3.74%
EBITDA	97.5M	107.1M	85.5M	100.1M	101.1M	109.4M	93.2M	100.3M	100.2M	114.6M	90M	106.4M
EPS	0.31	0.32	0.26	0.31	0.32	0.36	0.28	0.31	0.32	0.37	0.29	0.35
Diluted EPS	0.31	0.32	0.26	0.3	0.31	0.35	0.28	0.31	0.32	0.37	0.29	0.35

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	—	456.8M	—	—	—	5.4B	6B	4B	5.2B	3.4B
Enterprise value	—	—	946.9M	—	—	—	6.3B	6.9B	4.8B	6.2B	4.5B
Shares outstanding	23.4M	30.9M	32M	176.6M	201.9M	179.4M	181.1M	179M	171.6M	162.1M	162.1M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	—	—	—	36.2	22.6	18.8	24.9	17.5
P/S	—	—	0.24	—	—	—	1.38	1.4	0.8	0.91	0.61
P/B	—	—	-3.17	—	—	—	3.93	4.24	2.83	3.89	2.74
EV/EBITDA	—	—	12.1	—	—	—	19.4	14.5	12.1	15.2	11.2
EV/Sales	—	—	0.49	—	—	—	1.6	1.59	0.96	1.1	0.8
Earnings yield	—	—	—	—	—	—	2.76%	4.43%	5.32%	4.02%	5.72%
FCF yield	—	—	-0.4%	—	—	—	4.26%	5.46%	7.23%	4.2%	7.47%
PEG	—	—	—	—	—	—	—	—	—	—	1.35

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	28%	32.9%	21.8%	22.2%	22.5%	22.7%	22%	22.8%	20.3%	19.3%	18.5%
Operating margin	3.36%	4.73%	1.97%	-0.01%	3.65%	5.55%	6.09%	7.31%	6.44%	5.98%	5.9%
Net margin	-4.57%	-7.86%	-0.32%	-3.29%	-0.27%	4.07%	3.82%	6.21%	4.24%	3.67%	3.68%
ROE	127.2%	75.7%	4.25%	-8.37%	-0.8%	11.9%	10.9%	18.8%	15.1%	15.7%	16%
ROA	-7.07%	-10.6%	-1.05%	-2.93%	-0.31%	5.01%	4.84%	8.3%	6.19%	6.01%	6.17%
ROIC	7.7%	10.8%	11.1%	-0.01%	5.2%	8.61%	7.82%	10.4%	10.9%	10.5%	10.5%
Return on tangible assets	22.6%	37.9%	3.57%	7.35%	0.89%	-15.6%	-22.1%	-50%	-81.2%	-55.2%	-50.4%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.33	1.77	1.63	1.69	1.51	1.55	1.76	1.77	1.7	1.53	1.47
Quick ratio	1.05	1.41	1.38	1.34	1.15	1.15	1.36	1.33	1.2	0.96	0.98
Debt / equity	-13.4	-5.67	-3.5	1.51	1.2	0.99	0.83	0.82	0.87	0.96	1.01
Debt / assets	0.75	0.8	0.86	0.53	0.46	0.42	0.37	0.36	0.36	0.37	0.38
Net debt / EBITDA	5.42	3.67	6.27	24.3	6.18	4.12	2.65	1.74	2.03	2.55	2.61
Interest coverage	0.82	0.74	0.81	-0.06	0.95	2.74	4.82	8	6.78	6.19	6.27
Effective tax rate	0%	0%	0%	0%	0%	0%	26.8%	25.5%	25.3%	26.6%	26.6%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	39.9	26.4	60.6	13.1	15	19.2	21.8	24	29.1	34.9	36.2
EPS (basic)	-2.16	-2.36	-1.96	-1.96	-0.04	0.78	0.83	1.49	1.23	1.28	1.28
EPS (diluted)	-2.16	-2.36	-1.96	-1.96	-0.04	0.77	0.83	1.48	1.23	1.27	1.32
Book value per share	-1.43	-2.74	-4.5	5.14	5.03	6.56	7.65	7.94	8.18	8.18	8.41
FCF per share	-2.24	-0.31	-0.06	0.06	0.5	1.02	1.28	1.84	1.68	1.34	1.98
Cash per share	0.41	1.27	0.45	0.38	0.49	0.67	1.62	1.92	2.4	1.44	1.31
Capex per share	0.42	0.28	0.82	0.16	0.13	0.14	0.2	0.23	0.21	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	1.05%	1.06%	1.35%	1.22%	0.89%	0.75%	0.9%	0.97%	0.71%	—	—
Capex / operating cash flow	-52.7%	-124.9%	91.5%	77.9%	24.9%	14.4%	12.5%	11%	9.74%	—	—
Payout ratio	—	—	—	-2.63%	—	—	—	—	—	—	0%

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$1.1B	$1.1B	$1.1B	$1.2B	$1.3B	$1.3B	$1.3B	$1.4B	$1.4B	$1.5B	$1.4B	$1.4B
YoY change	+7.06%	+9.46%	+12.8%	+14.8%	+17%	+19.7%	+16.3%	+15.4%	+12.2%	+8.84%	+1.33%	+1.86%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	9.6M	39.5M	14.5M	67.1M	99.3M	119.4M	294.2M	343.8M	412.6M	232.6M
Receivables	109.1M	85.5M	114.9M	324.4M	328.3M	338.2M	377.5M	377.7M	409.7M	473.6M
Inventory	36.2M	38M	26.7M	115.9M	158.6M	183.1M	224.3M	274M	388.1M	471.1M
Total current assets	173.3M	186.6M	174.7M	558.7M	657M	710.3M	994.3M	1.1B	1.3B	1.3B
Property, plant & equipment	32.7M	27M	28.8M	196.7M	189.9M	186.3M	180.7M	204.8M	213.9M	230.5M
Goodwill & intangibles	794M	772.6M	755.3M	3.6B	3.6B	3.7B	3.8B	3.8B	3.7B	3.8B
Total assets	605M	603.1M	583.9M	2.6B	2.6B	2.8B	3.1B	3.2B	3.4B	3.5B
Accounts payable	64.4M	66M	67M	221.1M	282.9M	279.2M	378.8M	426.5M	610.8M	639.8M
Short-term debt	18.5M	1.7M	3.2M	29.6M	28.1M	25.1M	25.4M	24.3M	28.6M	30.8M
Total current liabilities	130.1M	105.1M	107.3M	330M	434M	459.7M	565.4M	618.3M	780.1M	829.3M
Long-term debt	433.4M	478.9M	501.5M	1.3B	1.2B	1.1B	1.1B	1.1B	1.2B	1.2B
Total liabilities	638.6M	687.8M	727.9M	1.7B	1.6B	1.6B	1.7B	1.8B	2B	2.1B
Shareholders' equity	-33.6M	-84.8M	-144M	906.8M	1B	1.2B	1.4B	1.4B	1.4B	1.3B
Total debt	451.9M	480.6M	504.7M	1.4B	1.2B	1.2B	1.2B	1.2B	1.2B	1.3B
Net debt	442.4M	441.1M	490.1M	1.3B	1.1B	1B	860.8M	822.6M	805.4M	1B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	386.5M	343.8M	219.5M	376.9M	483M	412.6M	171.4M	198.8M	309.8M	232.6M	177.3M	193.8M
Receivables	383M	377.7M	573.6M	468.3M	429M	409.7M	476.6M	481.3M	474.5M	473.6M	516.4M	356.6M
Inventory	251.4M	274M	241.9M	281.4M	310.6M	388.1M	369M	403.5M	415.7M	471.1M	415.7M	399.6M
Total current assets	1.1B	1.1B	1.1B	1.2B	1.3B	1.3B	1.1B	1.2B	1.3B	1.3B	1.2B	1.2B
Property, plant & equipment	191.7M	204.8M	208.8M	216.6M	215.1M	213.9M	222.2M	229.8M	226.7M	230.5M	229.7M	229.8M
Goodwill & intangibles	3.8B	3.8B	3.7B	3.7B	3.7B	3.7B	3.9B	3.9B	3.9B	3.8B	3.8B	3.8B
Total assets	3.2B	3.2B	3.2B	3.3B	3.4B	3.4B	3.3B	3.4B	3.5B	3.5B	3.4B	3.4B
Accounts payable	429.5M	426.5M	485.7M	535.7M	592M	610.8M	528.8M	590.2M	627.9M	639.8M	545M	639.8M
Short-term debt	24.5M	24.3M	25.2M	28.5M	28.5M	28.6M	29M	29.8M	30.3M	30.8M	30.8M	29.9M
Total current liabilities	624.1M	618.3M	637M	695.4M	763.2M	780.1M	713.7M	773.6M	823.9M	829.3M	729.7M	819.5M
Long-term debt	1.1B	1.1B	1.1B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B
Total liabilities	1.8B	1.8B	1.8B	1.9B	2B	2B	2B	2B	2.1B	2.1B	2B	2.1B
Shareholders' equity	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.3B	1.4B	1.3B
Total debt	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B	1.3B	1.3B	1.3B	1.3B
Net debt	780.4M	822.6M	951.2M	848.6M	738.5M	805.4M	1.1B	1B	966.4M	1B	1.1B	1.1B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	-36.2M	-63.3M	-6.1M	-75.9M	-8.1M	139.9M	150.6M	267.1M	211.8M	207.6M
Depreciation & amortization	22M	27.7M	41.1M	57.9M	77.9M	68.8M	65.4M	62.2M	63.5M	70.7M
Stock-based compensation	1.8M	2.4M	2.1M	4.2M	2.9M	9.6M	16.8M	30.5M	36.1M	40M
Change in working capital	-7.9M	22.7M	-11.4M	19.3M	3.8M	-31.2M	-23.5M	-13.4M	18.7M	-133.7M
Operating cash flow	-18.7M	-6.9M	28.7M	36.3M	108.1M	177.7M	282.5M	380.8M	365.5M	258.4M
Capital expenditure	-9.9M	-8.7M	-26.3M	-28.3M	-26.9M	-25.6M	-35.4M	-41.9M	-35.6M	—
Investing cash flow	-73.2M	-13.6M	-37M	-727.8M	-26.3M	-111.5M	-108.1M	-56.5M	-36.5M	-119.8M
Dividends paid	—	—	—	-2M	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	0	-250.3M	-252.7M	-310M
Financing cash flow	109.9M	43.2M	-4.2M	719.5M	-67.9M	-76.8M	-6M	-262M	-205.8M	-266.7M
Net change in cash	18M	22.6M	-12.4M	28M	13.8M	-10.6M	168.4M	62.3M	123.2M	-128M
Free cash flow	-52.4M	-9.4M	-1.8M	11.2M	100.5M	182.9M	232.2M	329.4M	287.8M	217.1M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	56.3M	57.2M	44.8M	53M	53.9M	60.1M	46.7M	50.5M	51.8M	58.5M	45.3M	53.9M
Depreciation & amortization	15.6M	15.8M	15.3M	15.5M	15.2M	17.5M	16.4M	17M	17M	20.3M	15.7M	18.4M
Stock-based compensation	9.2M	7.6M	9.6M	7.6M	10.4M	8.5M	8.8M	10.7M	11.1M	9.3M	10.2M	8.4M
Change in working capital	-14.2M	-10.1M	-111.8M	149.6M	65.6M	-45.2M	-129.5M	15.9M	30.4M	-50.5M	-86.1M	110.2M
Operating cash flow	73.2M	73.4M	-30.2M	236.9M	151.6M	46.7M	-47M	101.4M	139.4M	35.9M	-12.1M	183.6M
Capital expenditure	-8.4M	-19.9M	-5.8M	-9.8M	-9.7M	-10.3M	-9.4M	-9.1M	—	—	—	—
Investing cash flow	-8.4M	-15.8M	-5.8M	-9.8M	-9.7M	-10.3M	-126.7M	-9M	0	0	-274K	-603K
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	-100.1M	-75.2M	-40M	-78.1M	-42M	-92.6M	-100.2M	-52.2M	-62.5M	-95.1M	-17.5M	-153M
Financing cash flow	-101.6M	-76.7M	-41.5M	-79.7M	-41.6M	-94.2M	-99.9M	-53.8M	167M	-277M	-19.2M	-153.8M
Net change in cash	-36.8M	-19M	-77.6M	147.4M	100.4M	-57.9M	-273.6M	38.6M	306.5M	-241.1M	-31.6M	29.2M
Free cash flow	52.6M	31.1M	-74.6M	185.9M	150.7M	25.8M	-16.6M	81.2M	130.2M	22.2M	-21.2M	172.5M

Option Care Health Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement